AbCellera to present Phase 1/2 data for menopause hot-flash drug ABCL635 at TMS 2026 meeting

ABCL•2026-10-08

AbCellera said Phase 1/2 data for its non-hormonal menopause hot-flash drug ABCL635 are scheduled for a poster presentation at The Menopause Society’s annual meeting on Oct. 22, 2026. The reported readout includes safety, drug exposure, biological activity and early signs of symptom improvement.

AbCellera to present Phase 1/2 data for menopause hot-flash drug ABCL635 at TMS 2026 meeting

1. Poster presentation planned

Related News

Payoneer says ex-CEO Barak Eilam resigns from board, audit and risk committees

Kopin secures additional $18.6 million U.S. Army award for color microLED technology

Clearway Energy EVP and CFO Steven David Ryder files initial ownership statement

Enerpac Tool Group adds ex A.O. Smith CFO Charles Lauber to board

Worthington Steel president Clifford Larivey sells $8,000 in common shares